Delayed: ARP and 403(b) plan changes
Changes delayed for the Alternative Retirement Plan (ARP) and 403(b) program
As we have shared in prior communications, UC along with many other Ohio public universities, announced changes to its Alternative Retirement Plan (ARP) and 403(b) plans that were to be effective July 1, 2020.
The ARP is an offered alternative to the state retirement system (OPERS/STRS), and the university’s 403(b) is available for supplemental retirement plan savings. Changes to the ARP and the 403(b) include reducing the number of approved vendors in order to reduce plan and investment expenses as well as streamlining investment options so that enrollees can better create diversified investment portfolios and track fees.
However, given current market conditions along with concerns associated with COVID-19, we will delay implementing these changes. Delaying the implementation will allow us to reschedule the previously planned face-to-face town hall sessions. A delay will also allow affected employees future opportunities to schedule face-to-face appointments with their chosen vendors to discuss new plan investment options, etc. Such face-to-face scenarios are not possible in today’s environment.
Once a future implementation date is chosen, faculty and staff will be notified.
Questions?
Email the UC Benefits team at benefits@uc.edu.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.